Profile picture

Ms Janvi Sah

Ann Arbor (United States of America)
Follow
Logo ESC

Contributor content

Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients: a subgroup analysis of age
Presentation
Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients: a subgroup analysis of age
See more
Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients stratified by race
Presentation
Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients stratified by race
See more
Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients using five US databases: a subgroup analysis of chronic liver disease
Presentation
Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients using five US databases: a subgroup analysis of chronic liver disease
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources